EUVIMEDEUVIMED entdecken
Multizentrische Studie

Temperature‐controlled radiofrequency device treatment of septal swell bodies for nasal airway obstruction: An open‐label, single arm multicenter study

Jordan Pritikin, Stacey Silvers, Jeffrey Rosenbloom, Bryan Davis, Anthony Del Signore, Ahmad R Sedaghat iD, Bobby A Tajudeen, Isaac Schmale, Jack Lyons, Jacquelynne Corey, Rakesh Chandra

International Forum of Allergy & Rhinology · 2023-10 · 13 (10) · 1915-1925

DOI: 10.1002/alr.23156 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 27.03.2023. Verfasst von Jordan Pritikin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chicago Nasal & Sinus Center, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Nasal Obstruction, Rhinoplasty. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nasal airway obstruction (NAO) is a highly prevalent disorder. Septal swell body (SSB) hypertrophy is an often overlooked contributor to NAO. SSB treatment may relieve symptoms of NAO. The objective of this study was to assess the clinical use of a temperature‐controlled radiofrequency (TCRF) device to treat SSBs to improve symptoms in adults with NAO.

Methods

In this prospective, multicenter, open‐label, single arm study, patients with severe or extreme NAO related to SSB hypertrophy received bilateral TCRF treatment in the SSB area. The primary endpoint was improvement in Nasal Obstruction Symptom Evaluation (NOSE) Scale scores from baseline to 3 months postprocedure. A subset of study patients underwent computed tomography (CT) imaging to evaluate posttreatment changes in SSB size.

Results

Mean NOSE Scale scores significantly improved from 73.5 (SD 14.2) at baseline to 27.9 (SD 17.2) at 3 months postprocedure, a reduction of −45.3 (SD 21.4, 95% confidence interval [CI]: −50.4 to −40.1; p < 0.0001); the responder rate was 95.7% (95% CI: 0.88 to 0.99; p < 0.0001). CT evaluation at 3 months showed statistically significant reductions in the SSB with the greatest reduction in the middle thickness (mean change −3.4 [SD 1.8] mL, 95% CI: −4.0 to −2.8; p < 0.0001). Minimal adverse events with any relationship to the device or procedure were reported; none were serious in nature and no septal perforations occurred.

Conclusions

This study demonstrates that TCRF treatment of SSB hypertrophy is well tolerated and effective at reducing both SSB size and symptoms of NAO at 3 months posttreatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal ObstructionRhinoplastyAdultHumansProspective StudiesTemperatureNasal SeptumHypertrophyTreatment Outcome

Stichwörter der Autor:innen

NOSE Scalenasal congestionnasal septum deviationseptal swell bodyseptal turbinateseptoplastyturbinate hypertrophy

Autor:innen und Institutionen

  • Chicago Nasal & Sinus Center, Chicago, Illinois, USA.
  • Madison ENT & Facial Plastic Surgery, New York, New York, USA.
  • Alamo ENT Associates, San Antonio, Texas, USA.
  • Colorado ENT & Allergy, Colorado Springs, Colorado, USA.
  • Department of Otolaryngology - Head and Neck Surgery, Mount Sinai Hospital, New York, New York, USA.
  • Department of Otolaryngology - Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Ahmad R Sedaghat

Zitieren

APA

Pritikin, J., Silvers, S., Rosenbloom, J., Davis, B., Signore, A. D., Sedaghat, A. R., Tajudeen, B. A., Schmale, I., Lyons, J., Corey, J., & Chandra, R. (2023). Temperature‐controlled radiofrequency device treatment of septal swell bodies for nasal airway obstruction: An open‐label, single arm multicenter study. International Forum of Allergy & Rhinology, 13(10), 1915-1925. https://doi.org/10.1002/alr.23156

Vancouver

Pritikin J, Silvers S, Rosenbloom J, Davis B, Signore AD, Sedaghat AR, et al. Temperature‐controlled radiofrequency device treatment of septal swell bodies for nasal airway obstruction: An open‐label, single arm multicenter study. International Forum of Allergy & Rhinology. 2023;13(10):1915-1925. doi:10.1002/alr.23156

BibTeX
@article{Pritikin2023,
  author = {Pritikin, Jordan and Silvers, Stacey and Rosenbloom, Jeffrey and Davis, Bryan and Signore, Anthony Del and Sedaghat, Ahmad R and Tajudeen, Bobby A and Schmale, Isaac and Lyons, Jack and Corey, Jacquelynne and Chandra, Rakesh},
  title = {Temperature‐controlled radiofrequency device treatment of septal swell bodies for nasal airway obstruction: An open‐label, single arm multicenter study},
  journal = {International Forum of Allergy & Rhinology},
  year = {2023},
  volume = {13},
  number = {10},
  pages = {1915--1925},
  doi = {10.1002/alr.23156}
}
Kostenlos starten →